Market Overview and Dynamics
The Europe animal health market is projected to grow from US 24,271.1 million in 2018 to US 24,271.1 million in 2018 to US 37,605.1 million by 2027, expanding at a CAGR of 6.5% from 2019 to 2027. Key drivers of this growth include government initiatives and efforts by animal welfare associations to improve animal healthcare. However, the proliferation of counterfeit products could hinder market expansion.
Key Market Segments
By product, the prescription segment accounted for the largest market share in the Europe animal health market in 2018. In terms of animal type, the production animal segment held the largest market share of the animal health market by 2027.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 – https://www.businessmarketinsights.com/sample/TIPRE00013005
Major Sources and Companies Listed
Some of the major primary and secondary sources for animal health market included in the report are, Centers For Disease Control And Prevention (CDC), European Pet Food Industry Federation (FEDIAF), Veterinary Public Health Program (VPH), and among others. and others.
Reasons to buy the report
- To understand the animal health market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for animal health market
- Efficiently plan M&A and partnership deals in animal health market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form animal health market
- Obtain market revenue forecast for market by various segments from 2018-2027 in Europe region.
EUROPE ANIMAL HEALTH MARKET SEGMENTATION
| By Product | By Animal Type | By Geography | Company Profiles |
| Prescription | Production Animal | Europe | Boehringer Ingelheim International GmbH |
| Feed additives | Companion Animal | UK | Ceva Santé Animale |
| Pharmaceutical | Germany | Bayer AG |
| Vaccines | France | Vetoquinol SA |
| Diagnostics | Italy | Nutreco N.V. |
| Non-prescription | Spain |
| Nutrition/Supplements |
| Grooming Products |
| Parasiticides |
Europe Animal Health Strategic Insights – 2024 Update
The European animal health market is undergoing significant transformation, driven by regulatory changes, technological advancements, and shifting consumer demands. Stakeholders must adapt to evolving dynamics to maintain competitiveness and capitalize on emerging opportunities. Below are key strategic insights for the European animal health sector:
Europe Animal Health Regional Insights
The geographic scope of the Europe Animal Health refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Europe Animal Health Report Scope
| Report Attribute | Details |
| Market size in 2018 | US$ 24,271.1 Million |
| Market Size by 2027 | US$ 37,605.1 Million |
| Global CAGR (2019 – 2027) | 6.5% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered | By Product • Prescription • Non-Prescription By Animal Type • Production Animal • Companion Animal |
| Regions and Countries Covered | Europe • UK • Germany • France • Russia • Italy • Rest of Europe |
| Market leaders and key company profiles | • Boehringer Ingelheim International GmbH • Ceva Santé Animale • Bayer AG • Vetoquinol SA • Nutreco N.V. |
1. Market Overview & Key Trends
- Market Size & Growth: The European animal health market is projected to grow at a CAGR of ~5-6% (2024-2030), driven by increasing pet ownership, livestock production demands, and disease prevention measures.
- Regulatory Influence: The EU Veterinary Medicines Regulation (2019/6) continues to shape the industry, promoting antimicrobial stewardship and encouraging innovation in vaccines and digital health solutions.
- Sustainability & One Health: Growing emphasis on antibiotic reduction, animal welfare, and the One Health approach (linking animal, human, and environmental health) is reshaping product development.
2. Emerging Opportunities
a) Precision Livestock Farming (PLF) & Digital Health
- IoT-enabled wearables, AI-driven diagnostics, and automated farm management systems are gaining traction.
- Key players: MSD Animal Health, Zoetis, Connecterra, Smartbow.
- Actionable Insight: Invest in data-driven decision tools for farmers to optimize herd health and productivity.
b) Companion Animal Health Boom
- Pet humanization is driving demand for premium pet foods, insurance, and advanced therapeutics.
- Telemedicine for pets is expanding, with platforms like FirstVet and PawSquad gaining popularity.
- Actionable Insight: Develop personalized pet care solutions (e.g., nutraceuticals, genetic testing).
c) Alternative Proteins & Feed Additives
- With the EU’s Farm-to-Fork Strategy, demand for plant-based and insect-based feed is rising.
- Probiotics, prebiotics, and phage therapies are emerging as antibiotic alternatives.
- Actionable Insight: Partner with agri-tech startups to develop sustainable feed solutions.
3. Competitive Landscape & Key Players
- Top Companies: Zoetis, Boehringer Ingelheim, Elanco, MSD Animal Health, Ceva Santé Animale.
- Strategic Moves:
- Zoetis: Expanding into monoclonal antibodies for chronic pet conditions.
- Boehringer Ingelheim: Investing in African Swine Fever (ASF) vaccines.
- Startups: Companies like MicroSure (veterinary robotics) and PanoAI (AI diagnostics) are disrupting the market.
4. Regional Nuances
- Western Europe (Germany, France, UK): High pet care expenditure, strict regulations.
- Eastern Europe (Poland, Romania): Rapid growth in livestock production, increasing adoption of vaccines.
- Nordics (Sweden, Denmark): Leaders in antibiotic reduction and sustainable farming.
5. Future Outlook & Strategic Recommendations
- Anticipate Regulatory Shifts: Stay ahead of EU Green Deal compliance requirements.
- Leverage Digital Transformation: Adopt AI, blockchain for supply chain transparency.
- Focus on Sustainability: Develop eco-friendly packaging, carbon-neutral production.
- Collaborate with Startups: Accelerate innovation through venture investments & partnerships.
Conclusion
The European animal health market is evolving rapidly, with digitalization, sustainability, and regulatory changes as key drivers. Companies that embrace data-driven strategies, innovation in biologics, and precision livestock farming will gain a competitive edge. Stakeholders must adopt a future-oriented approach to navigate challenges and unlock growth in this dynamic sector.
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
